Supplemental Reading for Chapter 1 Basic Principles of Clinical ...
Supplemental Reading for Chapter 1 Basic Principles of Clinical ...
Supplemental Reading for Chapter 1 Basic Principles of Clinical ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5-10 Cardiovascular Pharmacotherapeutics<br />
243. Dargie HJ: Effect <strong>of</strong> carvedilol on outcome after<br />
myocardial infarction in patients with left ventricular<br />
dysfunction: the CAPRICORN randomized<br />
trial. Lancet 357: 1385,2001.<br />
244. Coreg CR (carvedilol phosphate) extended release<br />
capsules (package insert). Research Triangle Park,<br />
NC: GlaxoSmithKlein, 2007.<br />
245. International Collaborative Study Group: Reduction<br />
<strong>of</strong> infarct size with the early use <strong>of</strong> timolol in<br />
acute myocardial infarction. N Engl J Med 310:9-<br />
15, 1984.<br />
246. Hjalmarson A, Elmfeldt D, Herlitz J, et al: Effect<br />
<strong>of</strong> mortality <strong>of</strong> metoprolol in acute myocardial infarction.<br />
A double-blind randomised trial. Lancet<br />
2:823-827, 1981.<br />
247. MIAMI Trial Research Group: Metoprolol in acute<br />
myocardial infarction (MIAMI): a randomized<br />
placebo-controlled international trial. Eur Heart J<br />
6:199-226, 1985.<br />
248. ISIS-I collaborative Group: Randomized trial <strong>of</strong><br />
intravenous atenolol among 16,027 cases <strong>of</strong> suspected<br />
acute myocardial infarction: ISIS-I. Lancet<br />
2: 57, 1986.<br />
249. Muller J, Roberts R, Stone P, et al: Failure <strong>of</strong> propranolol<br />
administration to limit infarct size in<br />
patients with acute myocardial infarction (abstr).<br />
Circulation 68 (Suppl. III):III294, 1983.<br />
250. Barron HV, Rundle AC, Gore JM, et al <strong>for</strong> the Participants<br />
in the National Registry <strong>of</strong> Myocardial<br />
Infarction-2. Intracranial hemorrhage rates and effect<br />
<strong>of</strong> immediate beta-blocker use in patients with<br />
acute myocardial infarction treated with tissue<br />
plasminogen activators. Am J Cardiol 85:294, 2000.<br />
251. Pfisterer M, Cox JL, Granger CB, et al <strong>for</strong> the<br />
GUSTO-I Investigators: atenolol use and clinical<br />
outcomes after thrombolysis <strong>for</strong> acute myocardial<br />
infarction: the GUSTO-I experience. J Am Coll<br />
Cardiol 32:634, 1998.<br />
252. Phillips BG, Yim JM, Brown EJ Jr, et al: Pharmacologic<br />
pr<strong>of</strong>ile <strong>of</strong> survivors <strong>of</strong> acute myocardial<br />
infarction at United States academic hospitals. Am<br />
Heart J 131:872, 1996.<br />
253. Ayanian JZ, Hauptman PJ, Guadagnoli E, et al:<br />
Knowledge and practices <strong>of</strong> generalist and specialist<br />
physicians regarding drug therapy <strong>for</strong> acute<br />
myocardial infarction. N Engl J Med 331:1136,<br />
1994.<br />
254. Soumerai SB, McLaughlin TJ, Spiegelman D, et al:<br />
Adverse outcomes <strong>of</strong> underuse <strong>of</strong> beta blockers in<br />
elderly survivors <strong>of</strong> acute myocardial infarction.<br />
JAMA 277:115, 1997.<br />
255. Grand DA, Newcomer LN, Frieburger A, Tian H:<br />
Cardiologist’s practice compared with practice<br />
guidelines: use <strong>of</strong> beta blockade after acute myo-<br />
cardial infarction. J Am Coll Cardiol 26:1432, 1995.<br />
256. Phillips KA, Shlipak MG, Coxson P, et al: Health<br />
and economic benefits <strong>of</strong> increased b blocker use<br />
following myocardial infarction. JAMA 284:2748,<br />
2000.<br />
257. Chen J, Rad<strong>for</strong>d MJ, Wang Y, et al: Effectiveness <strong>of</strong><br />
beta blocker therapy after acute myocardial infarction<br />
in elderly patients with chronic obstructive<br />
pulmonary disease or asthma. J Am Coll Cardiol<br />
37:1950, 2001.<br />
258. Aronow WS, Ahn C: Effect <strong>of</strong> beta blockers on incidence<br />
<strong>of</strong> new coronary events in older persons<br />
with prior myocardial infarction and diabetes mellitus.<br />
Am J Cardiol 87:780, 2001.<br />
259. Rochon PA, Tu JV, Anderson GM, et al: Rate <strong>of</strong><br />
heart failure and 1-year survival <strong>for</strong> older people<br />
receiving low-dose b blocker therapy after myocardial<br />
infarction. Lancet 356:639, 2000.<br />
260. Barron HV, Viskin S: Dispelling the myths surrounding<br />
the use <strong>of</strong> beta blockers in patients after<br />
acute myocardial infarction. Prev Cardiol 3:13,<br />
1998.<br />
261. Krumholz HM, Rad<strong>for</strong>d MJ, Wang Y, et al: National<br />
use and effectiveness <strong>of</strong> b blockers <strong>for</strong> the<br />
treatment <strong>of</strong> elderly patients after acute myocardial<br />
infarction. National Cooperative Cardiovascular<br />
Project. JAMA 280:623, 1998.<br />
262. Krumholz HM, Rad<strong>for</strong>d MJ, Wang Y, et al: Early b<br />
blocker therapy <strong>for</strong> acute myocardial infarction in<br />
elderly patients. Ann Intern Med 131:648, 1999.<br />
263. Chen J, Marciniak TA, Rad<strong>for</strong>d MJ, et al: Beta<br />
blocker therapy <strong>for</strong> secondary prevention <strong>of</strong> myocardial<br />
infarction in elderly diabetic patients. J Am<br />
Coll Cardiol 34:1388, 1999.<br />
264. Gottlieb SS, McCarter RJ, Vogel RA: Effect <strong>of</strong> beta<br />
blockade on mortality among high-risk and lowrisk<br />
patients after myocardial infarction. N Engl J<br />
Med 339:489, 1998.<br />
265. Heller DA, Ahern FM, Kozak M: Changes in rates<br />
<strong>of</strong> b blocker use between 1994 and 1997 among elderly<br />
survivors <strong>of</strong> acute myocardial infarction. Am<br />
Heart J 140:663, 2000.<br />
266. Chen J, Rad<strong>for</strong>d MJ, Wang Y, et al: Are b blockers<br />
effective in elderly patients who undergo coronary<br />
revascularization after acute myocardial infarction?<br />
Arch Intern Med 160:947, 2000.<br />
267. The CAPRICORN Investigators: Effect <strong>of</strong> carvedilol<br />
on outcome after myocardial infarction in<br />
patients with left ventricular dysfunction: the<br />
CAPRICORN randomised trial. Lancet 357:1385,<br />
2001.<br />
268. Bradley EH, Holmboe ES, Matterna JA, et al: A<br />
qualitative study <strong>of</strong> increasing b blocker use after<br />
myocardial infarction. Why do some hospitals suc-
Change language